BackStealth BioTherapeutics Overview

Stealth BioTherapeutics Total Assets

Track Stealth BioTherapeutics's total assets ($37M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$36.91M
↑ 6.14% YoYΔ $2.13M vs prior year quarter

Peer trimmed avg / median

Loading

Stealth BioTherapeutics Total Assets History

Loading

Stealth BioTherapeutics vs. peers: Total Assets Comparison

Loading

Stealth BioTherapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Stealth BioTherapeutics (MITO) FAQ

The latest total assets for MITO is $37M as of March 2022. That compares with $35M in the prior-year period — up 6.1% year over year. Investors often review this figure alongside Stealth BioTherapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, MITO's total assets moved from $35M to $37M — a 6.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Stealth BioTherapeutics's operating scale or balance-sheet position.

A total assets figure of $37M for MITO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MITO's total assets ($37M), review year-over-year change from $35M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Stealth BioTherapeutics's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.